PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Section on Fibrotic Disorders, National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), Bethesda, Maryland, USA.\', \'Section on Medicinal Chemistry, National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), Bethesda, Maryland, USA.\', \'Laboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), Bethesda, Maryland, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/bph.15461
?:doi
?:hasPublicationType
?:journal
  • British journal of pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 33769552
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.603
?:rankingScore_hIndex
  • 186
is ?:relation_isRelatedTo_publication of
?:title
  • Dual inhibition of CB1 receptors and iNOS, as a potential novel approach to the pharmacological management of acute and long COVID-19.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33769552>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33769552>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all